Norbrook launches Loxicom for cats
Norbrook Laboratories Ltd has launched a new addition to the Loxicom range: Loxicom 0.5mg/ml Oral Suspension for Cats. Offering alleviation from inflammation and pain, Loxicom Oral Suspension for Cats is billed by Norbrook as 'the new cost-effective treatment for chronic musculo-skeletal disorders in cats that is bio-equivalent to the pioneer.' The Loxicom range now offers vet practices a choice between 5mg/ml Solution for Injection for Dogs and Cats, 1.5mg/ml Oral Suspension for Dogs and now 0.5mg/ml Oral Suspension for Cats. Loxicom Oral Suspension for Cats is available in a clear 15ml...